95268 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Cross-linked glycopeptide-cephalosporin antibiotics
#902GPR120 receptor agonists and uses thereof
#903N-PHENYL-METHANAMINE DERIVATIVE AND PESTICIDE CONTAINING IT
#904Spirocyclic tetronic acid derivatives
#905Use of ascorbic acid derivatives for the functionalization of matrices
#906Compositions and methods for inhibition of the JAK pathway
#907Purification of taxanes
#908ISOSELECTIVE POLYMERIZATION OF EPOXIDES
#909ACTINIC ENERGY RADIATION HARDENABLE COMPOSITION AND EPOXY COMPOUND
#910Heterocyclic compound and use thereof
#9116-phenylpyrimidinones as PIM modulators
#912Regulating Agent of GPR34 Receptor Function
#913Modulators of ATP-Binding Cassette Transporters
#914Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#915Compounds, compositions and methods
#916Compounds that inhibit human DNA ligases and methods of treating cancer
#917CRYSTALLINE FORM OF 1-CHOLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
#918Compounds for the treatment of hepatitis C
#919Compositions useful as inhibitors of voltage-gated sodium channels
#9203-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
#921Compound
#922Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors
#923Inhibitors of syk and JAK protein kinases
#924AMIDE COMPOUND
#925Inhibitors of papilloma virus
#926NOVEL FORMYL PEPTIDE RECEPTOR LIKE 1 AGONISTS THAT INDUCE MACROPHAGE TUMOR NECROSIS FACTOR ALPHA AND COMPUTATIONAL STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF THEREOF
#927NOVEL CHROMENE AND THIOCHROMENE CARBOXAMIDE DERIVATIVES, METHODS FOR PREPARING SAME AND THERAPEUTIC APPLICATIONS OF SAME
#928HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY
#9292,4-disubstituted pyrimidines useful as kinase inhibitors
#930IDENTIFICATION OF ANTI-CANCER COMPOUNDS AND COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE AND METHODS OF TREATMENT THEREOF
#931Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#932AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE
#933ANTIVIRAL PROTEASE INHIBITORS
#934C-10 carbamates of taxanes
#935EPONEMYCIN AND EPOXOMICIN ANALOGS AND USES THEREOF
#936HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION
#937Low pressure carbonylation of heterocycles
#938Macrocyclic compounds and their use as kinase inhibitors
#939BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
#940Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives
#941Nitroso compounds as nitroxyl donors and methods of use thereof
#942Aryl sulfonamides useful as inhibitors of chemokine receptor activity
#943VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
#944Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders
#945Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them
#946Anthranilic acid derivative or salt thereof
#947Kinase Inhibitors
#948Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
#949N-(Hetero)Aryl Indole Derivatives as Pesticides
#950MACROLIDE CONJUGATES OF PYRROLIZINE AND INDOLIZINE COMPOUNDS AS INHIBITORS OF 5-LIPOOXYGENASE AND CYCLOOXYGENASE
#951Isoflavone derivatives and pharmaceutical compositions comprising the same
#952C-8 HALOGENATED MACROLIDES
#953Therapeutic substituted lactams
#954Heterocyclic antiviral compounds
#955ANTI-PROLIFERATIVE COMPOUNDS FROM A 3-ARYL-COUMARINE OR 3-ARYL-QUINOLIN-2-ONE AND USES THEREOF
#956Flavonoid dimers and methods of making and using such
#957Novel Antigiardial Agents and Methods of Use Thereof
#958AZACYCLIC COMPOUNDS
#959Novobiocin analogues having modified sugar moieties
#960Photopolymerizable monomers having epoxide and unsaturated double bonds and their composition
#961Nitrogen-containing heterocyclic compound and use thereof
#962Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same
#963EPreceptor antagonists
#964Quinazoline derivatives having tyrosine kinase inhibitory activity
#9655-substituted benzofurans as inhibitors of cytochrome P450 2D6
#966Fused heterocyclic compounds and their use as sirtuin modulators
#967Fungicide N-cyclopropyl-sulfonylamide derivatives
#968Benzylbenzene derivatives and methods of use
#969Synthesis of quaternary salt compounds
#970Synthesis of quaternary salt compounds
#971Antiviral protease inhibitors
#972Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
#973Pyrazine compounds and uses as PI3K inhibitors
#974DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
#975Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#976BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE
#977Heteroaroyl-substituted Alanines
#978COMPOUNDS AND METHODS OF USE
#979Belactosin derivatives as therapeutic agents/biological probes and their synthesis
#980Leptomycin compounds
#981Novel Cercosporamide Derivative
#982Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
#983Bicyclic compound, production and use thereof
#984NEW EPOTHIOLONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR PHARMACEUTICAL USE
#985Novel Adamantane Derivatives
#986Compounds, compositions and methods
#987Method for purifying dianhydrides
#988Modulation of bacterial quorum sensing with synthetic ligands
#989IRNA agents targeting CCR5 expressing cells and uses thereof
#990Inhibitors of post-proline cleaving proteases
#991Process for preparing substituted diaminopyrimidine oximes
#992Permanent surface modifiers
#993Potassium channel blockers and uses thereof
#994Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
#995Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
#996Compositions and methods for inhibition of the JAK pathway
#997Reworkable thermosetting resin composition
#998Paclitaxel enhancer compounds
#999MODULATORS OF ACETYL-COENZYME A CARBOXYLASE AND METHODS OF USE THEREOF
#1000Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists
#1001Cross-linked glycopeptide-cephalosporin antibiotics
#1002Cross-linked glycopeptide-cephalosporin antibiotics
#1003PI-3 kinase inhibitor prodrugs
#1004Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
#1005Modulators of ATP-binding cassette transporters
#1006Bicyclic compound, production and use thereof
#1007Retroviral protease inhibiting compounds
#1008Decahydronaphthalene compounds
#1009Method of making bisimides
#1010Fluorinated bis (phthalic anhydride) and method for producing the same
#1011Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states
#1012Inhibitors of sodium glucose co-transporter 2 and methods of their use
#1013Cross-linked glycopeptide-cephalosporin antibiotics
#1014Compounds which modulate the CB2 receptor
#1015Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing α-keto amide compound using them
#1016Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
#1017Epoxyketone-based immunoproteasome inhibitors
#1018Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them
#1019Cross-linked glycopeptide-cephalosporin antibiotics
#1020Method of inhibiting C-KIT kinase
#1021Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#1022Cross-linked glycopeptide-cephalosporin antibiotics
#1023Organic Compounds and Their Uses
#1024Cross-linked glycopeptide-cephalosporin antibiotics
#1025EPreceptor antagonists
#1026Cross-linked glycopeptide-cephalosporin antibiotics
#1027Ink composition and inkjet ink, and image-forming method and recorded material using the same, and oxetane compound
#1028Benzofurans as potassium ion channel modulators
#1029INHIBITORS OF CATHEPSIN S
#1030N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines
#1031Modulators of melanocortin receptor
#1032Tri(cyclo) substituted amide compounds
#1033Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives
#1034Glucose transport inhibitors and methods of use
#1035Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
#1036N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
#1037Substituted pyrimidinyl oxime kinase inhibitors
#1038Antidiabetic bicyclic compounds
#1039Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
#1040Phosphodiesterase 4 inhibitors
#1041C7 ESTER AND C10 HYDROXY SUBSTITUTED TAXANES
#1042TAXANES HAVING C7 HYDROXY AND C10 HETEROSUBSTITUTED ACETATE SUBSTITUENTS
#1043Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-(()-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
#1044Hydroxamic acid esters and pharmaceutical use thereof
#1045Diamino-1,3,5-triazines N-substituted with bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators
#1046Hedgehog pathway antagonists
#1047Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
#1048Low pressure carbonylation of heterocycles
#1049TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND FORMULATIONS
#1050COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#1051Novel Saccharothrix Strain an Antibiotics Derived Therefrom, i.e. Mutactimycins and Aldgamycins
#1052Substituted hydantoins
#1053Esters of flavonoids with w-substituted c6-c22 fatty acids
#1054Opioid receptor antagonists
#1055Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
#1056Imino ether derivative compounds and drugs containing the compounds as the active ingredient
#1057Novel heterocycles
#1058Fumagillol derivative and the medical use thereof
#1059Modified lysine-mimetic compounds
#1060Nonsteroidal progesterone receptor modulators
#1061Aminodibenzodioxin derivative and organic electroluminescent using the same
#10624,4,5,5, tetrasubstituted imidazolines
#1063EPreceptor antagonists
#1064Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
#1065Vitamin D receptor modulators
#1066Taxane metabolites
#1067Alkynyl aryl carboxamides
#1068Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof
#1069HIV protease inhibitors
#1070Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
#1071Method for purifying oxybisphthalic anhydrides
#1072Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#1073Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
#1074Multivalent inhibitors of serum amyloid P component
#1075Ambruticin VS compounds
#1076Quaternary salt CCR2 antagonists
#1077Fumagillol derivatives and preparing method thereof
#1078Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds
#1079Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
#1080Composition for oral administration containing alkylene dioxybenzene derivative
#1081Monoamine re-uptake inhibitors and methods relating thereto
#1082Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-(()-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
#1083Mchir antagonists
#1084Cyclopentapyridine and tetrahydroquinoline derivatives
#1085Dihydrobenzofuran derivatives and uses thereof
#1086Inhibitors of papilloma virus
#1087Tocopherol-modified therapeutic drug compounds
#1088Non-steroidal farnesoid x receptor modulators
#1089Substituted chroman derivatives
#1090Azacyclic compounds
#1091Azacyclic compounds
#1092Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
#1093Inhibitors of c-fms kinase
#1094Tetrahydropyran compounds as tachykinin antagonists
#1095Sulfonamide inhibitors of aspartyl protease
#1096Heterocycle-hydrazone based charge transport materials
#1097Inhibitors of c-fms kinase
#1098Chromones and chromone derivatives and uses thereof
#1099Non-steroidal farnesoid X receptor modulators and methods for the use thereof
#1100Paclitaxel enhancer compounds
#1101Antigiardial agents and use thereof
#1102Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
#1103Amino acid analogues
#1104Aromatic sulfone hydroxamic acid metalloprotease inhibitor
#1105Hydroxamic acid and amide compounds and their use as protease inhibitors
#1106Modulators of ATP-binding cassette transporters
#1107Vanilloid receptor ligands and their use in treatments
#1108Compositions useful as inhibitors of voltage-gated sodium channels
#1109D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture
#1110Compounds, compositions and methods
#1111Substituted aryl thioureas and related compounds; inhibitors of viral replication
#1112Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#1113Reworkable thermosetting resin composition
#1114Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#1115Vanilloid receptor ligands and their use in treatments
#1116Vanilloid receptor ligands and their use in treatments
#1117Vanilloid receptor ligands and their use in treatments
#1118Biphenyl carboxamides
#1119Vanilloid receptor ligands and their use in treatments
#1120Leptomycin compounds
#1121Vanilloid receptor ligands and their use in treatments
#1122Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#1123Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
#1124Cross-linked glycopeptide—cephalosporin antibiotics
#1125Vanilloid receptor ligands and their use in treatments
#1126Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
#11272,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
#1128C7 lactyloxy-substituted taxanes
#1129Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
#1130PI-3 kinase inhibitor prodrugs
#11316-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-1-benzopyran derivatives as 5-lipoxygenase inhibitor
#1132Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
#1133Benzofuran derivatives, their production and use
#1134C10 carbamoyloxy substituted taxane compositions
#11352-cyano-4-fluoropyrrolidine derivative or its salt
#1136Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
#11372-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
#1138Vanilloid receptor ligands and their use in treatments
#1139Compounds and methods
#1140Benzopyran compounds useful for treating inflammatory conditions
#1141Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
#1142Modulators of ATP-binding cassette transporters
#1143Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
#1144HIV protease inhibiting compounds
#1145Non-steroidal farnesoid X receptor modulators and methods for the use thereof
#1146C10 heterosubstituted acetate taxane compositions
#1147Taxanes having a C7 heterosubstituted acetate substituent
#1148Benzodioxole derivatives
#1149Histone deacetylase inhibitors
#1150Benzyl sulfonamide derivatives
#1151Compositions useful as inhibitors of voltage-gated sodium channels
#1152Inhibitors of cathepsin S
#1153Substituted cyclic compounds
#1154Benzylcycloalkyl amines as modulators of chemokine receptor activity
#1155Compounds and methods of use
#1156Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
#1157Piperidine compounds
#1158Eponemycin and epoxomicin analogs and uses thereof
#1159Aromatic sulfone hydroxamic acids and their use as protease inhibitors
#1160Tocopherol-modified therapeutic drug compounds
#1161Novel adamantane derivatives
#1162Aryl sulfonamides useful as inhibitors of chemokine receptor activity
#1163Cytotoxic agents containing novel potent taxanes and their therapeutic use
#1164Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
#1165Tricyclic compounds with antiviral activity
#1166Substituted cyclic compounds
#1167Coumarin derivative
#1168Coumarins as iNOS inhibitors
#1169Antagonists of MCP-1 function and methods of use thereof
#1170Substituted benzopyran derivatives for the treatment of inflammation
#1171HIV integrase inhibitors
#1172Inhibitors of dipeptidyl peptidase IV
#11733-Amino chroman and 2-amino tetralin derivatives
#1174Cytotoxic agents containing novel potent taxanes and their therapeutic use
#1175Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors
#1176Fluorinated bis(phthalic anhydride) and method for producing the same
#1177C7 carbamoyloxy substituted taxane compositions
#1178Cyclic compound and PPAR agonist
#1179Azacyclic compounds
#1180Taxol enhancer compounds
#1181Inhibitors of papilloma virus
#1182Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
#1183N-[(2-{[(furan-ylcarbonyl)carbamothioyl]amino }phenyl)carbamothioyl]furan-2-carboxamide as an eco-friendly insecticidal agent against (boisd.)
#11842,4-disubstituted pyrimidines useful as kinase inhibitors
#1185Capsaicinoid prodrug compounds and their use in treating medical conditions
#1186Processes for producing beta-lactone with heterogenous catalysts
#1187Method for target substance detection and measurement
#1188Method for target substance detection and measurement